Proteomic mapping associated with clinical and sociodemographic parameters of breast cancer in Senegal
Authors:
- Malick FallMFMalick Fall
- Moussa CamaraMCMoussa Camara
- Omar NiangONOmar Niang
- Fatimata MbayeFMFatimata Mbaye
- Ahmadou DemADAhmadou Dem
- Sidy KaSKSidy Ka
- Mamadou Aliou DialloMDMamadou Aliou Diallo
- Julie HardouineJulie Hardouine
- Silly ToureSTSilly Toure
- Ndongo DiaNDNdongo Dia
- Mbacké SembeneMSMbacké Sembene
- Pascal CosettePCPascal Cosette
Open Access
- 16 December 2025
- journal article
- Published by Universidad Tecnica de Manabi in International journal of health sciences
- Vol. 9 (3) , 961-980
Abstract
Breast cancer refers to a malignant tumour resulting from the uncontrolled proliferation of epithelial cells in the mammary gland. It is the leading cause of cancer in women. In Senegal, regional disparities remain marked by differences in access to screening, diagnosis, and treatment. Proteomics provides a direct reflection of the functional state of tissues and biological pathways and captures the functional effects of molecular alterations. In order to better understand the relationship between the pathogenesis of breast cancer and the existence of potential biomarkers based on each underlying clinical and sociodemographic parameter, this study performs correlation analyses. Proteins were extracted from healthy and cancerous tissues. The analytical workflow showed 30 proteins that were statistically deregulated between those under and over 50 years of age, 5 proteins between married and unmarried patients, 37 proteins between women with fewer than 7 children and those with more than 7 children, six proteins between the early stage and the locally advanced stage, and treatment response showed that 17 proteins were statistically deregulated. The results of this study have identified numerous proteins with high prognostic value associated with robust statistics and significantly overexpressed according to the parameters.Keywords
This publication has 39 references indexed in Scilit:
- Identification of a Biomarker Panel in Extracellular Vesicles Derived From Non‐Small Cell Lung Cancer (NSCLC) Through Proteomic Analysis and Machine LearningJournal of Extracellular Vesicles, 2025
- UBC9: a novel therapeutic target in papillary thyroid carcinomaJournal of Endocrinological Investigation, 2025
- SERPING1 Reduces Cell Migration via ERK‐MMP2‐MMP‐9 Cascade in Sorafenib‐ Resistant Hepatocellular CarcinomaEnvironmental Toxicology, 2024
- IGFALS suppresses hepatocellular carcinoma progression by stabilizing PPAR-γInternational Immunopharmacology, 2024
- MATR3 promotes liver cancer progression by suppressing DHX58–mediated type I interferon responseCancer Letters, 2024
- Prognostic significance of MATR3 in stage I and II non-small cell lung cancer patientsJournal of Cancer Research and Clinical Oncology, 2022
- SPTBN1 inhibits growth and epithelial-mesenchymal transition in breast cancer by downregulating miR-21European Journal of Pharmacology, 2021
- The Matrisome Genes From Hepatitis B–Related Hepatocellular Carcinoma UnveiledHepatology Communications, 2021
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- Label-free quantification in clinical proteomicsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2013